GENERAL ESSAYS
PREFERENCE-BASED OUTCOME MEASURES IN COST-UTILITY ANALYSES: A 20-year Overview
- Dan Greenberg, Joseph S. Pliskin
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 461-466
-
- Article
- Export citation
-
Objectives: The study evaluated the extent to which quality-adjusted life-years (QALYs) and healthy-years equivalents (HYEs) were used in cost-utility studies over the past 20 years (1981–2000) as well as possible changes in the quality of journals reporting cost-utility studies.
Methods: Cost-utility studies were identified through an electronic search. For each study the journal name, date of publication, article's language and research origin, and the journal's impact factor were recorded.
Results: The number of published cost-utility studies increased in the last 20 years but has leveled off in 1997. Most studies were performed in the United States and were published in English. All studies except one used QALYs as an outcome measure. The mean journal's impact factor has changed slightly over the years.
Conclusions: Cost-utility studies would possibly gain more popularity if they were used as a vehicle in the decision-making process regarding healthcare budgets and were more visible in the scientific literature.
HEALTHY-YEAR EQUIVALENTS IN MAJOR JOINT REPLACEMENT: Can Patients Provide Meaningful Responses?
- Hilary A. Llewellyn-Thomas, Rena Arshinoff, Mary Bell, Jack Ivan Williams, C. David Naylor
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 467-484
-
- Article
- Export citation
-
Objectives: Healthy-years equivalents (HYEs) have been proposed as an evaluative measure with advantages over quality-adjusted life-years (QALYs). The main purpose was to assess the feasibility of eliciting HYEs from patients who have undergone major joint replacement; a secondary objective was to examine relationships with postsurgical health status.
Methods: Pre- and postsurgical reports of perceived comorbidity and current arthritic burden were obtained from 194 patients, using a comorbidity checklist, summary scores from the Western Ontario/McMaster Osteoarthritis Questionnaire (WOMAC), summary scores derived from six Likert scales, and holistic utility scores for the same attributes. After surgery, HYEs for the full across-time health profile were also elicited.
Results: All measures of arthritic burden were sensitive to pre/postsurgical changes (p = .0001), and comorbidity scores were stable. Two HYE subgroups emerged. An HYE-invariant subgroup ascribed full HYEs to their profiles, while reporting higher Likert (t = 2.1309; p = .0344) and utility (s = 4.1504; p = .0001) scores for their postsurgical health state. An HYE-variant subgroup reported HYEs that were weakly but significantly (p < .009) correlated with Likert (r = .30), utility (rs = .25), and comorbidity (r = −.26) scores for their postsurgical state.
Conclusions: Our results indicate that patients can understand the HYE assessment procedures and provide interpretable responses. However, a significant proportion reports invariant HYEs that could inflate estimates of the overall mean HYE. Further exploration of the HYEs reported by different clinical and attitudinal populations is needed before widespread adoption of this measure.
COST-UTILITY ANALYSIS OF PATIENT CARE IN CHILDREN WITH MENINGEAL SIGNS
- Rianne Oostenbrink, Jan B. Oostenbrink, Karel G. M. Moons, Gerarda Derksen-Lubsen, Marie-Louise Essink-Bot, Diederick E. Grobbee, W. Ken Redekop, Henriëtte A. Moll
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 485-496
-
- Article
- Export citation
-
Objectives: We designed a model of diagnostic and therapeutic interventions applied in children with meningeal signs. Using this model, we determined in a cost-utility analysis the consequences for society of different diagnostic strategies in terms of quality-adjusted life-years (QALYs) and costs.
Methods: Data were used from 360 children (0.1–15 years) visiting the pediatric emergency department of the Sophia Children's Hospital Rotterdam, The Netherlands (1988–98) with meningeal signs. Model inputs included probabilities of meningitis and adverse outcome, QALYs for years lived with long-term sequelae, and costs of tests and treatments. Mean outcome measures were costs and effects of diagnostic and therapeutic interventions in children suspected of bacterial meningitis, key determinants of the model outcomes, and evaluation of alternative diagnostic strategies and two vaccination programs in an analysis.
Results: The population comprised 99 children with bacterial meningitis (adverse outcome in 10), 36 with serious other bacterial infections, and 225 with self-limiting diseases. Key determinants were the risk of bacterial meningitis or sequelae, costs of treatment, and long-term morbidity. Minimizing lumbar punctures and empirical treatments using a diagnostic decision rule, without missing a single case of meningitis, was a dominant strategy to actual practice. Vaccination strategies of Streptococcus pneumoniae and Neisseria meningitidis resulted in our model in incremental cost-utility ratios of 401,965 Euro dollar ()/QALY and 22,635/QALY, respectively.
Conclusions: Costs of long-term morbidity of bacterial meningitis largely outweigh diagnostic and treatment costs. Modeling interventions in children at risk of bacterial meningitis should include long-term consequences in terms of costs and QALYs.
CLINICAL AND COST-EFFECTIVENESS OF DONEPEZIL, RIVASTIGMINE, AND GALANTAMINE FOR ALZHEIMER'S DISEASE: A Systematic Review
- Andrew Clegg, Jackie Bryant, Tricia Nicholson, Linda McIntyre, Sofie De Broe, Karen Gerard, Norman Waugh
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 497-507
-
- Article
- Export citation
-
Objectives: Systematic review of the clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for people suffering from Alzheimer's disease.
Methods: Sixteen electronic databases (including MEDLINE, the Cochrane Library, and Embase) and bibliographies of related papers were searched for published/unpublished English language studies, and experts and pharmaceutical companies were consulted for additional information. Randomized controlled trials (RCTs) and economic studies were selected. Clinical effectiveness was assessed on measurement scales assessing progression of Alzheimer's disease on the person's global health, cognition, functional ability, behavior and mood, and quality of life. Cost-effectiveness was presented as incremental cost per year spent in a nonsevere state (by Mini Mental Health State Examination) or quality-adjusted life-year.
Results: Twelve of 15 RCTs included were judged to be of good quality. Although donepezil had beneficial effects in Alzheimer's patients on global health and cognition, rivastigmine on global health, and galantamine on global health, cognition, and functional scales, these improvements were small and may not be clinically significant. Measures of quality of life and behavior and mood were rarely assessed. Adverse effects were usually mild and transient. Cost-effectiveness base case estimates ranged from £2,415 savings to £49,476 additional cost (1997 prices) per unit of effect for donepezil and a small savings for rivastigmine. Estimates were not considered robust or generalizable.
Conclusions: Donepezil, rivastigmine, and galantamine appear to have some clinical effect for people with Alzheimer's disease, although the extent to which these translate into real differences in everyday life remains unclear. Due to the nature of current economic studies, cost-effectiveness remains uncertain and the impact on different care sectors has been inadequately investigated. Further research is needed to establish the actual benefits of acetylcholinesterase inhibitors (AChEls) for people with Alzheimer's disease and their caregivers, the relationship of these changes to clinical management, and careful prospective evaluation of resource and budgetary consequences.
ECONOMIC EVALUATION OF ANTINEOPLASIC CHEMOTHERAPY ADMINISTERED AT HOME OR IN HOSPITALS
- Raphaël Remonnay, Yves Devaux, Franck Chauvin, Eric Dubost, Marie Odile Carrère
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 508-519
-
- Article
- Export citation
-
Objectives: Comparative economic evaluations of chemotherapy administered in hospital day-care units or in the home are relatively scarce. Furthermore, most existing evaluations do not include methodologic studies. This study seeks to compare the costs of anticancer chemotherapy with hospital at-home care versus a hospital day-care unit in the Rhône-Alpes region of France.
Methods: This study is based on a randomized controlled crossover trial that included 42 patients, to whom chemotherapy courses were alternatively given in both settings. All cost categories were taken into account according to microcosting methods. A detailed assessment was performed on coordination and health care in both structures (marginal costs and average costs), from the viewpoint of society.
Results: The marginal cost for one chemotherapy administration was significantly higher with hospital at-home care than in the hospital day-care unit ($232.5 vs. $157, p < .0001). Conversely, the average cost was significantly lower with home care than at the hospital ($252.6 vs. $277.3, p = .0002).
Conclusions: The results show that the interest of developing home care in anticancer chemotherapy is questionable regarding costs. In the French healthcare system, where there is a surplus of hospital beds, marginal costs seem to be more relevant indicators in most cases than average costs.
USE AND COST OF ASSISTIVE TECHNOLOGY THE FIRST YEAR AFTER STROKE: A Randomized Controlled Trial
- Gunilla Gosman-Hedström, Lisbeth Claesson, Christian Blomstrand, Björn Fagerberg, Birgitta Lundgren-Lindquist
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 520-527
-
- Article
- Export citation
-
Objective: The objective was to compare and evaluate assistive technology given to patients treated in a stroke unit and patients treated in a general medical ward.
Method: Use and cost of assistive technology was evaluated in a randomized study comprising 249 patients during a 12-month period.
Result: Acute stroke unit care was associated with a higher prescription of assistive devices during the first 3 months. There was no difference in use and total mean cost per patient of assistive technology during the first year after stroke.
Conclusion: There was no difference in use or cost of assistive technology during the first year, but a beneficial effect was found on supplementary prescription of assistive devices during the first 3 months. The cost during the first year after stroke was a small fraction of the total costs for care and rehabilitation. It is a not expensive for the community to equip these patients and their caregivers with assistive technology, and economic resources should be available to this vulnerable group of elderly patients.
DEVELOPMENT OF A QUESTIONNAIRE TO MEASURE HEARING-RELATED HEALTH STATE PREFERENCES FRAMED IN AN OVERALL HEALTH PERSPECTIVE
- Manuela Joore, Daniëlle Brunenberg, Horst Zank, Hans van der Stel, Lucien Anteunis, Gijs Boas, Hans Peters
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 528-539
-
- Article
- Export citation
-
Objectives: The objective was to develop the Audiological Disabilities Preference Index (ADPI), a measure to determine health state preferences associated with audiological disabilities. The ADPI consists of a hearing-related health state description, hearing-related health state valuation, and transformation of the latter to the overall health scale. Research questions were: a) to determine the feasibility of ADPI in an older hearing-impaired population; b) to assess gain in health state preference after hearing aid fitting; c) to evaluate the reliability of ADPI using hypothetical health states; and d) to compare the results of ADPI with the EuroQol.
Methods: The ADPI, the marker states, and the EuroQol were administered to 78 first-time hearing aid users before and 12 and 25 weeks after hearing aid fitting.
Results: The ADPI was feasible in an older hearing-impaired population (mean age, 69.1 years). After hearing aid fitting, all dimensions of audiological disability improved (p < .001). Change in hearing-specific health state and the latter framed in overall health were 0.27 and 0.12, respectively (p < .001). The mean values of the marker states were stable, but the intraclass correlation coefficients were low. Correlations between ADPI and hearing loss and the EuroQol, respectively, were low, while moderate with hearing aid satisfaction. There was a slight change on the EuroQol visual analog scale, with only an improvement in the feeling dimension (p < .05).
Conclusions: The ADPI provides a practical and useful method to assess hearing-related health state preferences needed for clinical decision making and cost-effectiveness analysis.
EFFECTS OF LINEZOLID ON HOSPITAL LENGTH OF STAY COMPARED WITH VANCOMYCIN IN TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS INFECTIONS: An Application of Multivariate Survival Analysis
- Richard J. Willke, Henry A. Glick, Jim Z. Li, Brian E. Rittenhouse
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 540-554
-
- Article
- Export citation
-
Objectives: This study was designed to estimate the effects of treatment with linezolid as compared with vancomycin, on the distribution of length of stay (LOS) for hospitalized patients with methicillin-resistant staphylococcal infections. Treatment with intravenous–oral linezolid may allow some patients to be discharged earlier than would treatment with intravenous vancomycin.
Methods: The analysis is based on the intention-to-treat sample from a randomized multinational phase 3 clinical trial of 460 patients showing that the treatments had equal efficacy. Given the nature of the LOS data, some censoring, and some imbalances between treatment groups, multivariate survival analysis was indicated. Cox proportional hazards assumptions were tested and failed, and accelerated failure time models were tested for best fit. The log-logistic model was selected and used as the basis for estimating the overall treatment effect on LOS. Two methods for multivariate corrections to the survivorship functions allowed more thorough description of the treatment effect on the distribution of LOS, including multivariate-adjusted Kaplan-Meier curves.
Results: The average reduction in LOS associated with linezolid treatment, based on the log-logistic model after correction for covariate effects, was 18.1\% (p = .041) or 2.53 days at the median. This was consistent with differences at the medians of the adjusted survivorship functions, which were 2 or 3 days depending on the method used. Treatment-based differences exist at each decile of LOS and consistently favor linezolid. Estimated mean reduction in LOS due to linezolid was 1.62 days in both methods.
Conclusions: In this study sample, linezolid treatment resulted in statistically significantly shorter hospital LOS as compared with vancomycin treatment. Appropriate use of multivariate survival analysis allows better examination of the nature of the treatment effect on LOS, which may be important for economic analysis.
IN VITRO TESTS FOR ASSESSING HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIENTS AFTER ELECTIVE HIP REPLACEMENT: A Medico-economical Evaluation
- Frédéric Sobas, Cyrille Colin, Patrick Ffrench, Marie Christine Trzeciak, Marc Dechavanne, Claude Négrier
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 555-565
-
- Article
- Export citation
-
Objectives: Considering the previously published incidences of heparin-induced thrombocytopenia (HIT) in patients receiving a thromboprophylactic therapy, the role of the hemostasis laboratory is essential in making a clinical decision. The purpose of this project was to compare the strategies of diagnosis and associated care of patients with suspected HIT after elective hip replacement using platelet aggregation assay, carbon 14-serotonin release, and “doing nothing.”
Methods: The authors used an incremental cost-effectiveness analysis based on data extracted from the literature. The effectiveness of the strategies was represented by the number of deep venous thromboses prevented. Cost data were collected from the observation of biological and medical practice at Edouard Herriot University Hospital, Lyon, France, in 1999.
Results: In comparison with the strategies of doing nothing using no biological test for diagnosis, and clinical care of HIT-suspected patients, the strategy using platelet aggregation test was more expensive and less effective. With respect to the strategy using carbon 14-serotonin release assay, the incremental cost-effectiveness ratio, expressed as U.S. dollars per deep venous thrombosis prevented, reached $200,000, with a marginal effectiveness of eight deep venous thromboses prevented for 10,000 HIT-suspected patients.
Conclusion: This study suggests that clinical hemostasis laboratories might consider replacing the platelet aggregation test with the carbon 14-serotonin release assay or should use another functional assay such as the flow cytometric assay for the diagnosis and care of patients with suspected HIT.
DO CHANGES IN SURGICAL PROCEDURES FOR BREAST CANCER HAVE CONSEQUENCES FOR HOSPITAL MEAN LENGTH OF STAY?: A Study of Women Operated on for Breast Cancer in Sweden, 1980–95
- Rikard Lindqvist, Torgil R. Möller, Magnus Stenbeck, Finn Diderichsen
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 566-575
-
- Article
- Export citation
-
Background: Between 1986 and 1996, the overall mean overnight length of stay for all diagnoses in Sweden decreased from 20.8 to 7.1 days.
Objectives: The study describes changes in surgical technique, from mastectomy to breast-conserving surgery, in treatment of female breast cancer and the parallel change in average length of hospital stay, and discusses the possible link between the trends.
Research Design: The study was performed as a descriptive register study on hospital admission data from the Swedish Hospital Discharge Register over a 16-year period (1980–95).
Results: During the study period, the mean length of stay for surgical curative breast cancer treatment in Sweden decreased by 56%. In 1980, the proportion of women receiving conservative surgery was 7%. At the end of the period, this share had increased to 51%. Breast-conserving surgery had an approximately 30% shorter mean length of stay compared with mastectomy. The gap was remarkably stable during the study period. The shift from mastectomy to breast-conserving surgery had a limited effect on the share of patients that went through lymph node dissection. Neither age nor the number of operations per woman could, to any significant extent, explain the decrease in mean length of stay. Approximately 14% of the overall decline can be attributed to the changes in technique.
Conclusions: Clinical practice style, in this case the surgical technique, has had an effect on length of stay, but the surgical technique can only to some extent explain the trend.
STAGING OF NON–SMALL-CELL LUNG CANCER AND APPLICATION OF FDG-PET: A Cost Modeling Approach
- Paul Verboom, G. Judith M. Herder, Otto S. Hoekstra, Egbert F. Smit, Jan H. A. M. van den Bergh, Piet C. M. van Velthoven, Els W. M. Grijseels
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 576-585
-
- Article
- Export citation
-
Background: The presence of (distant) metastases affects the therapy (operation) and prognosis of patients with non–small-cell lung cancer (NSCLC). Fifty percent of the operations are futile due to the presence of a locally advanced tumor or distant metastases. Therefore, more accurate preoperative staging is required with respect to the outcomes (reduction of futile operations) and costs. This study examines current staging procedures and assesses possible situations for incorporating positron emission tomography (PET).
Methods: A retrospective analysis was performed to assess actual clinical practice in the staging procedure of 337 patients with NSCLC in two Dutch hospitals. Consequently, by combining these data of actual clinical practice with a literature review, a model was developed to determine the influence of PET on the staging outcomes and the costs. In this model the accuracy and costs of PET can be varied as well as the extent of substitution of conventional diagnostic tests by PET.
Results: Practice variation was found between the two hospitals with regard to the setting in which the diagnostic staging took place (hospitalization, outpatient setting) and the extent of the use of mediastinoscopy. This was reflected in the costs and in the number of (futile) operations.
Conclusion: Hospitalization is the major cost driver in these patients. From a cost viewpoint, the evaluation of PET in a strategy after diagnostic imaging but prior to invasive staging seems most optimal.
PRIMARY CARE GUIDELINES ON CONSULTATION PRACTICES: THE EFFECTIVENESS OF COMPUTERIZED VERSUS PAPER-BASED VERSIONS: A Cluster Randomized Controlled Trial Among Newly Qualified Primary Care Physicians
- Jukkapekka Jousimaa, Marjukka Mäkelä, Ilkka Kunnamo, Graeme MacLennan, Jeremy M. Grimshaw
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 586-596
-
- Article
- Export citation
-
Objective: To compare the effects of computerized and paper-based versions of guidelines on recently qualified physicians' consultation practices.
Methods: Two arm cluster randomized controlled trial. Physicians were randomized to receive computerized or textbook-based versions of the same guidelines for a 4-week study period. Physicians' compliance with guideline recommendations about laboratory, radiological, physical and other examinations, procedures, nonpharmacologic and pharmacologic treatments, physiotherapy, and referrals were measured by case note review.
Results: There were 139 recently qualified physicians working in 96 primary healthcare centers in Finland who participated in the study. Data on 4,633 patient encounters were abstracted, of which 3,484 were suitable for further analysis. Physicians' compliance with guidelines was high (over 80% for use of laboratory, radiology, physical examinations, and referrals). There were no significant differences in physicians' consultation practices in any of the measured outcomes between the computerized and textbook group.
Conclusion: Guidelines are a useful source of information for recently qualified physicians working in primary care. However, the method of presentation of the guidelines (electronic or paper) does not have an effect on guideline use or their impact on decisions. Other factors should be considered when choosing the method of presentation of guidelines, such as information-seeking time, ease of use during the consultation, ability to update, production costs, and the physicians' own preferences.
RECOMMENDATIONS FOR THE PREVENTION OF OSTEOPOROSIS AND FRAGILITY FRACTURES: International Comparison and Synthesis
- Michel Rossignol, Yola Moride, Sylvie Perreault, Jean-François Boivin, Louis-Georges Ste-Marie, Yvonne Robitaille, Louise Poulin de Courval, Bruno Fautrel
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 597-610
-
- Article
- Export citation
-
Objectives: This review included the following objectives: a) to synthesize recommendations made by public agencies in Western countries concerning screening for osteoporosis; b) to compare these recommendations and sort out the similarities and discrepancies; and c) to propose a strategy for the fight against osteoporosis and fragility fractures.
Methods: Eleven reports published by publicly financed agencies were included in the analysis: three international, four North American and four European agencies. Transcriptions of recommendations and arguments were classified using criteria for evaluation of screening technologies.
Results: Of eight reports that made a recommendation on mass screening, four made a recommendation against the use of densitometry, two remained vague with a conditionally positive recommendation, and two made no recommendation, arguing insufficient scientific evidence. Concerning screening of asymptomatic women in the perimenopause period, recommendations were uniformly opposed to the use of bone densitometry in five of nine reports, and the other four made no recommendation, arguing insufficient scientific evidence. Some of the discrepancies can be explained by the different definitions given to osteoporosis and by the confusion of terms between screening and diagnostic testing. A strategy is proposed to ensure that all women who are at risk of osteoporosis and fragility fracture have access to preventive measures. This strategy is based on the complementarity and coordination of roles between health promotion interventions and clinical interventions.
Conclusions: Prevention of osteoporosis and fragility fractures is an attainable goal. Existing resources are currently badly targeted. Compromises must be negotiated between the different stakeholders and biomedical disciplines to achieve efficiency and accessibility in the reduction of fragility fractures. A first compromise to reconcile social and scientific realities would be to use a best-evidence synthesis instead of an evidence-based medicine approach in future analyses and recommendations by public authorities. A second compromise would be to recognize the complementary roles of public health and clinical professionals toward the common objective of preventing fragility fractures.
HOW TO REPORT AND MONITOR THE PERFORMANCE OF WAITING LIST MANAGEMENT
- Markus Torkki, Miika Linna, Seppo Seitsalo, Pekka Paavolainen
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 611-618
-
- Article
- Export citation
-
Objectives: Potential problems concerning waiting list management are often monitored using mean waiting times based on empirical samples. However, the appropriateness of mean waiting time as an indicator of access can be questioned if a waiting list is not managed well, e.g., if the queue discipline is violated. This study was performed to find out about the queue discipline in waiting lists for elective surgery to reveal potential discrepancies in waiting list management.
Methods: There were 1,774 waiting list patients for hallux valgus or varicose vein surgery or sterilization. The waiting time distributions of patients receiving surgery and of patients still waiting for an operation are presented in column charts. The charts are compared with two model charts. One model chart presents a high queue discipline (first in—first out) and another a poor queue discipline (random) queue.
Results: There were significant differences in waiting list management across hospitals and patient categories. Examples of a poor queue discipline were found in queues for hallux valgus and varicose vein operations.
Conclusions: A routine waiting list reporting should be used to guarantee the quality of waiting list management and to pinpoint potential problems in access. It is important to monitor not only the number of patients in the waiting list but also the queue discipline and the balance between demand and supply of surgical services. The purpose for this type of reporting is to ensure that the priority setting made at health policy level also works in practise.
A COMPARISON OF THE RESULTS OF CHECKED VERSUS UNCHECKED INDIVIDUAL PATIENT DATA META-ANALYSES
- Sarah Burdett, Lesley Anne Stewart
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 619-624
-
- Article
- Export citation
-
Objectives: Systematic reviews and meta-analyses of individual patient data involve the central collection, validation, and reanalysis of raw data from randomized controlled trials. Checking individual patient data before its inclusion in a meta-analysis involves a number of different procedures that can be both time- and resource-intensive. We therefore aimed to assess the utility of data checking by investigating whether checks made any appreciable difference to the results of an individual patient data meta-analysis.
Methods: Data that were included in a meta-analysis of postoperative radiotherapy in non–small-cell lung cancer were used in a comparison of checked and unchecked data to investigate whether checking impacted the final results of the meta-analysis. Data “as received” were compared with fully checked and with followed-up data.
Results: Checking influenced the results, in this case mainly due to the exclusion of a single trial that failed to meet checking procedures. Checking data from most trials had only a small effect and did not materially alter the overall results of the meta-analysis.
Conclusions: Although data checking and cleaning is time-consuming, and for the majority of trials may make little difference to the analysis, such procedures provide a useful safeguard against rare occurrences of data with major problems. Checking may also lend additional confidence in the data set, which may be particularly important when using unpublished data that has not been subject to standard peer review.
THE IMPACT OF ENDOMETRIAL ABLATION ON HYSTERECTOMY RATES IN WOMEN WITH BENIGN UTERINE CONDITIONS IN THE UNITED STATES
- Cynthia M. Farquhar, Sandra Naoom, Claudia A. Steiner
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 625-634
-
- Article
- Export citation
-
Objective: To assess the impact of endometrial ablation on the utilization of hysterectomy in U.S. women with benign uterine conditions.
Methods: Data are from the State Inpatient and Ambulatory Surgery Databases of the Healthcare Cost and Utilization Project for six states, 1990–97. Women who underwent hysterectomy (ICD-9-CM codes 68.3, 68.4, 68.5, 68.51, 68.59, 68.9) and endometrial ablation (68.23, 69.29) and had benign uterine conditions (ICD-9-CM code 218.0 and CCS groupings 47, 171, 173, 175, 176, 215) were extracted. Comparative rates, length of stay, total charges, age, payer, hospital, and teaching status of the hospital are reported.
Results: The rates of hysterectomy decreased in three states: Colorado (37% decrease; 33 per 10,000 women in 1990 to 21 per 10,000 in 1997), Maryland (18% decrease; 17/10,000 in 1990 to 14/10,000 in 1997), and New Jersey (11% decrease; 9/10,000 to 8/10,000); were static in two states (Connecticut and New York) and increased in one state, Wisconsin (11% increase; 19/10,000 in 1994 to 21/10,000 in 1997). The rates for endometrial ablation increased in all states. The ratio of hysterectomy rates to endometrial ablation rates fell in each state across the 7 years. In two states (New York and New Jersey) the rate of endometrial ablation was equivalent to the rate of hysterectomies by 1997. The total combined rate for hysterectomy and endometrial ablation for women with benign uterine conditions for each state increased by more than 10%, with the exception of Maryland, which had an increase of only 5%, and Colorado, which had a decline of 23%.
Conclusions: In the six states studied, the diffusion of endometrial ablation has had a varying impact on hysterectomy rates among women with benign uterine conditions. However, endometrial ablation is used as an additive medical technology rather than a substitute.
A NEW INDEX APPROACH TO MEASURE LOST BENEFITS FROM PROGRESSION TO BLINDNESS
- Rikard Althin, Mats Lundström, Pontus Roos
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 635-644
-
- Article
- Export citation
-
Objectives: An index approach for measuring the reduction in daily activities of patients suffering from an eye disease associated with progressive visual loss is proposed. The approach is illustrated using data collected from patients with cataract.
Method: The approach uses recently developed methods based on index theory together with measurements of daily activities. In a simulation based on observations of visual acuity and daily activities in patients with cataract, indexes of changes in benefits were estimated for varying levels of visual acuity.
Results: Results show the development of loss in benefits resulting from a progressive deterioration in visual acuity. The results indicate a 40% loss in benefits at low levels of visual acuity, equivalent to a potential increase in benefits of 75% for these individuals following successful treatment.
Conclusions: The proposed index approach may prove useful for measuring reductions in daily activities resulting from the progressive loss of vision in eye disease. The approach has successfully measured the reduction in daily activities in patients with cataract and may be applicable in patients with other eye diseases, including age-related macular degeneration and open-angle glaucoma.
STATUS AND POTENTIAL OF GENE THERAPY IN CLINICAL MEDICINE: Assessment of an Emerging Health Technology Through Systematic Survey of Clinical Gene Therapy Protocols and Published Results
- Anita Lyngstadaas
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 645-674
-
- Article
- Export citation
-
Objective: Somatic gene therapy is a new method in the rapidly expanding field of molecular medicine. Due to recent encouraging results and the promising prospect for some disease groups, Norwegian health authorities wanted to assess somatic therapy with evidence-based standards for strategic use. This article presents the results of this assessment, discussed in the context of the policy-making process in Norway, including ethical and legislational considerations.
Methods: Clinical gene therapy protocols, ongoing or completed with published results, where available, were identified through a systematic survey of descriptive protocols and publications. Preclinical literature was also reviewed.
Results: Gene therapy is dominated by preclinical and clinical research. Most of the gene therapy protocols identified are in early phases (phases I and II) with only a few patients in each study. Of the protocols included in the assessment, only three phase III studies are represented. Except for the use of soluble antisense oligonucleotides against cytomegalovirus eye infection, gene therapy is presently not an established treatment modality. Promising results have been observed in treatment of cancer and cardiovascular diseases and, most recently, in inherited severe combined immunodeficiency and hemophilia. Several interesting principles addressing a large panel of conditions are currently being developed and tested.
Conclusions: Gene therapy is developing into an important medical concept that needs to be included within the Norwegian healthcare system. It is recommended that the Norwegian Ministry of Health and Social Affairs fund a national program to boost infrastructure in selected scientific groups both in preclinical and clinical research. The national procedures regulating approval of gene therapy trials should be made more efficient while at the same time allowing for proper control and ethical considerations. It is emphasized that gene therapy trials should be carefully monitored for side effects.
IS THERE A TECHNOLOGICAL IMPERATIVE IN HEALTH CARE?
- Bjørn Hofmann
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 675-689
-
- Article
- Export citation
-
The question in the title will be addressed by first answering the question: What is a technological imperative? A review of the literature makes it clear that there are many descriptions and explanations of the technological imperative in health care, and that not all of them are important to consider. One conception of the technological imperative that is important is the one that implies that technology reduces our responsibility toward our actions. I argue that that this conception cannot be justified. That is, there is no imperative that frees us from our responsibility for developing, producing, advertising, assessing, implementing, using, and banishing technology in health care. On the contrary, the increased possibilities provided by technology result in an increased responsibility. That is, there is no technological imperative, but technology promotes a moral imperative; in particular, it promotes a moral imperative to proper assessment.
DIFFUSION AND UTILIZATION OF MAGNETIC RESONANCE IMAGING IN ASIA
- Raymond C. W. Hutubessy, Piya Hanvoravongchai, Tessa Tan-Torres Edejer
-
- Published online by Cambridge University Press:
- 19 December 2002, pp. 690-704
-
- Article
- Export citation
-
Objectives: An assessment of the current status of magnetic resonance imaging (MRI) was undertaken to provide input for future government decisions on the introduction of new technologies in Asia. The objective of the study is to describe and explain the diffusion pattern of this costly technology in several Asian settings.
Methods: Data on the diffusion pattern of MRI for different Asian countries (the Republic of Korea, Malaysia, Indonesia, the Philippines and Thailand) and regions (the cities of Shanghai and Hong Kong in China and the state of Tamil Nadu in India) were obtained from national representatives of professional bodies by using standardized questionnaires for the year 1997–98. In addition, utilization data were collected at the hospital level in three countries before and after the economic crisis in the region. For four countries plus Hong Kong, background information on the legal framework for “big ticket” technologies was collected.
Results: Since the introduction of the first MRI in the region in 1987, the number of MRIs has gradually increased both in public and private facilities in Asia. In 1998 the average number of MRI machines installed varied from less than 0.5 machine per million population to more than 5 machines per million population. The maintenance and operating costs, and not the absence of regulation, account for the low number of MRIs in the Philippines and Malaysia. Overall, installed MRIs have low magnetic field strength, vary with respect to brand and type, and are mostly in the private sector and in the urban areas of the region. The diffusion pattern of MRIs in countries of the Asian region appears to follow two types of patterns of diffusion: one set of countries seems to be composed of mostly early adopters and another set of countries appears to be composed mostly of late adopters.
Conclusions: Total number of MRIs per population in this region, though quite small compared to most OECD countries, reflects a higher share of the country's healthresource devoted to expensive high-technology devices. It is difficult to state the appropriate number of MRIs for each country; however, the study shows that there are observable problems in terms of efficiency, equity, and quality of MRI services. The research team proposes a few key recommendations to counteract these problems. Purchasing and regulatory bodies must be empowered with skill and knowledge of health technology assessment. Likewise, the fundamental problems resulting from inefficient and unfair health financing should not be overlooked, so that there is more equitable use of the technology.